we develop for patients
Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then select large pharmaceutical commercialization partners for out-licensing to maximize patient access across the globe.
Through this specialized business model, Debiopharm can focus on the development of prescription drugs that target unmet medical needs in oncology and bacterial infections.
Debiopharm completed the development and has licensed out 2 compounds: - Triptorelin, the active substance of Decapeptyl®/Trelstar®/Pamorelin®/Triptodur® 1, 3 and 6-month formulation and Moapar®/Salcacyl® -Oxaliplatin, the active substance of the branded Eloxatin®/Elplat®/Dacotin®/Dacplat®
If your university or biotech start-up has interesting molecules in early-stage research and you’re seeking a competent and committed partner to develop them further, please contact us!
drug development, digital health, oncology, antimicrobials, Healthcare, Biopharmaceutical, drug delivery, and Science and innovation
Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial infections. Our main activities include drug development, drug manufacturing and digital health investment.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Sifted Newspaper Publishing | Sifted Newspaper Publishing | Other 20 Oct 2023 | | |
Novo Nordisk Pharmaceutical, Pharmaceutical Manufacturing | Novo Nordisk Pharmaceutical, Pharmaceutical Manufacturing | Other 6 Mar 2023 | | |
Omnes Startup accelerator & VC, Financial Services | Omnes Startup accelerator & VC, Financial Services | Other 13 Mar 2023 | | |
Pharma IQ Pharmaceutical, Pharmaceutical Manufacturing | Pharma IQ Pharmaceutical, Pharmaceutical Manufacturing | Other 6 Apr 2023 | | |
WILCO Software Development | WILCO Software Development | Other 19 Sep 2022 | | |
Innovaud International Trade and Development | Innovaud International Trade and Development | Other 10 Feb 2023 | |